4D Molecular Therapeutics, Inc. (FDMT)
15.22
+0.54
(+3.68%)
USD |
NASDAQ |
Sep 18, 16:00
15.08
-0.14
(-0.92%)
After-Hours: 20:00
4D Molecular Therapeutics Market Cap : 840.36M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 840.36M |
| September 17, 2026 | 810.54M |
| September 16, 2026 | 759.75M |
| September 15, 2026 | 752.57M |
| September 14, 2026 | 759.75M |
| September 11, 2026 | 727.17M |
| September 10, 2026 | 744.84M |
| September 09, 2026 | 782.94M |
| September 08, 2026 | 807.78M |
| September 04, 2026 | 826.56M |
| September 03, 2026 | 811.65M |
| September 02, 2026 | 824.90M |
| September 01, 2026 | 792.32M |
| August 31, 2026 | 779.07M |
| August 28, 2026 | 809.99M |
| August 27, 2026 | 823.24M |
| August 26, 2026 | 859.13M |
| August 25, 2026 | 867.97M |
| August 24, 2026 | 849.74M |
| August 21, 2026 | 874.04M |
| August 20, 2026 | 888.95M |
| August 19, 2026 | 925.39M |
| August 18, 2026 | 812.75M |
| August 17, 2026 | 803.09M |
| August 14, 2026 | 673.06M |
| Date | Value |
|---|---|
| August 13, 2026 | 643.24M |
| August 12, 2026 | 655.39M |
| August 11, 2026 | 633.31M |
| August 10, 2026 | 582.31M |
| August 07, 2026 | 561.92M |
| August 06, 2026 | 551.47M |
| August 05, 2026 | 537.35M |
| August 04, 2026 | 536.31M |
| August 03, 2026 | 527.42M |
| July 31, 2026 | 532.12M |
| July 30, 2026 | 526.38M |
| July 29, 2026 | 502.33M |
| July 28, 2026 | 514.88M |
| July 27, 2026 | 542.58M |
| July 24, 2026 | 526.38M |
| July 23, 2026 | 542.58M |
| July 22, 2026 | 572.90M |
| July 21, 2026 | 594.59M |
| July 20, 2026 | 579.69M |
| July 17, 2026 | 574.46M |
| July 16, 2026 | 566.62M |
| July 15, 2026 | 610.53M |
| July 14, 2026 | 611.58M |
| July 13, 2026 | 590.67M |
| July 10, 2026 | 643.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 208.48B |
| AnaptysBio, Inc. | 1.603B |
| Precision BioSciences, Inc. | 176.31M |
| Design Therapeutics, Inc. | 765.98M |
| Inhibrx Biosciences, Inc. | 1.608B |
Market Cap Related Metrics
| PS Ratio | 10.42 |
| Price to Book Value | 2.061 |
| Price | 15.22 |
| Earnings Yield | -17.90% |